ICON plc has announced a significant expansion of its oncology research capabilities by partnering with the Brian Moran Cancer Institute at Duly Health and Care in Illinois. This new collaboration enhances ICON’s Accellacare Site Network, strengthening support for oncology clinical trials and increasing patient access to innovative cancer treatments. The institute features a team of 14 medical oncologists, three radiation oncologists, and nine fellowship-trained surgical specialists across various cancer disciplines. This development builds on Accellacare’s existing oncology expertise and reflects ICON’s commitment to advancing cancer research and improving clinical trial recruitment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ICON plc published the original content used to generate this news brief via Business Wire (Ref. ID: 20260127530337) on January 27, 2026, and is solely responsible for the information contained therein.